Some drugs, such as the Chi3l1 inhibitor K284-6111, can attenuate memory impairment and neuroinflammation by modulating the NF-κB and ERK-PTX3 pathways, thus potentially preventing AD development [302,303]. This evidence concerns the gene PTX3 and Alzheimer disease.